| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc06cad2b58bbfcc30e3c96a6eb6c926 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366 |
| filingDate |
2018-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb9b97c9b45b992d46af00da826dc558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3692a8c10c6a77ff6fc2ce466b5f94eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22dbccc6b2545a9f6c19b81c07fe2b04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be8873615f613942fc51e269c2bd11b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48920e112afd304ed8d3e924aa665987 |
| publicationDate |
2019-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201936184-A |
| titleOfInvention |
Use of a pharmaceutical composition for selectively killing oral cancer cells and an active ingredient thereof |
| abstract |
The present invention provides a use of a compound represented by the following formula (I) for the preparation of a medicament for selectively killing an oral cancer cell, The compound represented by the formula (I) is sinularin, and has the effect of selectively killing the oral cancer cells. |
| priorityDate |
2018-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |